CSPG4-specific monoclonal antibody (mAb) inhibited TNBC cell migration and growth, caused significant regression of lung metastasis, and limited tumor recurrence in a mouse immunodeficient in situ xenograft model. Here, CSPG4 is linked to neoplasm.